Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-03 Purchase |
2025-04-04 07:30 am |
Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO |
5,500 | $1.8382 | $10,110 | 347,420 (Indirect Direct) |
View |
| 2024-10-23 Purchase |
2024-10-24 08:30 am |
Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO |
500 | $3.915 | $1,958 | 335,195 (Indirect Direct) |
View |
| 2024-10-15 Purchase |
2024-10-16 08:31 am |
Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO |
250 | $2.9 | $725 | 334,695 (Indirect Direct) |
View |
| 2024-10-10 Purchase |
2024-10-15 08:31 am |
Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO |
1,150 | $2.5835 | $2,971 | 334,445 (Indirect Direct) |
View |
| 2024-03-13 Purchase |
2024-03-14 8:51 pm |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
2,000 | $7.29 | $14,580 | 326,770 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-27 Option Award |
2025-03-31 4:30 pm |
N/A 2035-03-28 |
Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO |
33,625 | $0 | 368,820 (Direct) |
View |
| 2024-03-28 Option Award |
2024-03-28 5:57 pm |
N/A 2024-03-28 |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
33,625 | $0 | 360,195 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-13 6:30 pm |
N/A 2033-03-09 |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
20,000 | $0 | 338,770 (Direct) |
View |
| 2022-08-23 Conversion |
2023-03-13 6:30 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
6,649,610 | $0 | 338,770 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:01 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
250,000 | $0 | 479,014 (Direct) |
View |
Ownership |
2022-05-26 4:15 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Gilad Oren President |
0 | $0 | 884,678 (Direct) |
View |